drugset / Trial / NCT03183557

Efficacy of Zoledronic Acid in Osteoporosis

NCT03183557

Phase 2 Unknown 100 enrolled Shinshu University
RandomizedParallel-groupSingle-blindTreatment

Summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

Timeline

Start
2017-10-12
Primary completion
2022-12-08
Completion
2025-06-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alfacalcidol Other / unclassified
Comparator Zoledronic acid Other / unclassified

Indications